The High Court has recently issued a significant decision which could make it easier to patent AI inventions at the…Read More
Service: Life Sciences
2023 Patent Landscape Report: COVID-19-related vaccines and therapeutics
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….Read More
Unravelling the mysteries of motor neurone disease
Motor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…Read More
Do safety regulations inhibit innovation in the aerospace sector?
Reading this headline, you might think that safety inhibiting innovation isn’t a bad thing. Stockton Rush, founder of OceanGate® Expeditions…Read More
Energy giants advance investment to accelerate clean energy solutions
According to the IEA report ‘Emissions from Oil and Gas Operations in Net Zero Transitions’, oil and gas operations account…Read More
Why the EPO’s Enlarged Board of Appeal’s decision in G2/21 will impact inventions relating to life sciences and chemistry
The European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…Read More
Get ready for the Unitary Patent and Unified Patent Court to go live: 1 June 2023
The current go-live date for the Unitary Patent (UP) and the Unified Patent Court (UPC) is 1 June 2023. For…Read More
Lecanemab: could the drug with modest benefits make a big difference to Alzheimer’s patients?
Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple…Read More
To UPC, or not UPC: have you decided yet?
The Unitary Patent (UP) and the Unified Patent Court (UPC) is now expected to go live in early 2023. The…Read More
Don’t fall into an indefensible opposition trap – you can use a routine pre-grant patent check in Europe
Many European patent applications are prosecuted through to grant where through determined and persuasive argument, luck, or an Examiner oversight,…Read More
How do I decide whether to opt out of the Unified Patent Court?
The European Patent Office (EPO) and participating European Union countries are in the final stages of establishing the Unitary Patent…Read More
The verdict is in: it’s a yes from the FDA for the controversial Alzheimer’s drug, after a tricky year for Biogen
The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…Read More